Order Article Reprints

Overby SJ, Cerro-Herreros E, Espinosa-Espinosa J, González-Martínez I, Moreno N, Fernández-Costa JM, Balaguer-Trias J, Ramón-Azcón J, Pérez-Alonso M, Møller T, et al. BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA^LR Mice. Pharmaceutics. 2023; 15(4):1118. https://doi.org/10.3390/pharmaceutics15041118

Overby, Sarah J., Estefanía Cerro-Herreros, Jorge Espinosa-Espinosa, Irene González-Martínez, Nerea Moreno, Juan M. Fernández-Costa, Jordina Balaguer-Trias, Javier Ramón-Azcón, Manuel Pérez-Alonso, Thorleif Møller, and et al. 2023. "BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA^LR Mice" Pharmaceutics 15, no. 4: 1118. https://doi.org/10.3390/pharmaceutics15041118

Overby, S. J., Cerro-Herreros, E., Espinosa-Espinosa, J., González-Martínez, I., Moreno, N., Fernández-Costa, J. M., Balaguer-Trias, J., Ramón-Azcón, J., Pérez-Alonso, M., Møller, T., Llamusí, B., & Artero, R. (2023). BlockmiR AONs as Site-Specific Therapeutic MBNL Modulation in Myotonic Dystrophy 2D and 3D Muscle Cells and HSA^LR Mice. Pharmaceutics, 15(4), 1118. https://doi.org/10.3390/pharmaceutics15041118